当前位置：
X-MOL 学术
›
Drug Design Development and Therapy
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo
Drug Design Development and Therapy Pub Date : 2020-02-23 , DOI: 10.2147/dddt.s203048 Yuhui Hua 1 , Weijia Wang 1 , Xiaoli Zheng 2 , Ling Yang 2 , Hongjin Wu 2 , Zhaoyang Hu 2 , Ying Li 2 , Jing Yue 2 , Zhenzhen Jiang 2 , Xiaoyan Zhang 2 , Qiang Hou 2 , Shixiu Wu 3
中文翻译：
JAK2激酶抑制剂NVP-BSK805在体外和体内显着增强食管鳞状细胞癌的放射敏感性
更新日期：2020-02-23
Drug Design Development and Therapy Pub Date : 2020-02-23 , DOI: 10.2147/dddt.s203048 Yuhui Hua 1 , Weijia Wang 1 , Xiaoli Zheng 2 , Ling Yang 2 , Hongjin Wu 2 , Zhaoyang Hu 2 , Ying Li 2 , Jing Yue 2 , Zhenzhen Jiang 2 , Xiaoyan Zhang 2 , Qiang Hou 2 , Shixiu Wu 3
Affiliation
中文翻译：
JAK2激酶抑制剂NVP-BSK805在体外和体内显着增强食管鳞状细胞癌的放射敏感性
京公网安备 11010802027423号